Surfix’s photonic diagnostics platform with lab-level precision

Surfix’s mission is to advance global health by delivering accurate, accessible, and affordable diagnostic solutions for disease detection and management, specifically in underserved Point-of-Care (POC) testing segments.

To achieve this goal, Surfix has developed a photonic diagnostics platform that delivers exceptional sensitivity, accuracy, and a broad dynamic range. This cutting-edge technology enables diagnostics with precision surpassing traditional laboratory standards – a POCT with beyond lab-level precision.

Surfix’s objective is to continuously enhance the platform, ensuring it remains easy to use while offering reliable and sensitive detection of a wide array of biomarkers. By doing so, Surfix is committed to elevating healthcare standards and making advanced diagnostics accessible globally.

General Information

Surfix
IVAM member
Agro Business Park 2
6708PW Wageningen
Netherlands
Number of Employees: 25
Founding Year: 2011

Contact

Dr. L.M.W. Scheres
+31 85 488 1285

Latest news

Cancer diagnostics in transition: COMPAMED Innovation Forum 2025 provides insights into the future
02.04.2025 Cancer diagnostics is at a turning point: new technologies are fundamentally changing how we recognize, understand and treat diseases. This …